Hosted on MSN2mon
Candel Therapeutics Stock More Than Doubles After Strong Prostate Cancer Trial Results: Retail Goes Wild
as the clinical-stage biopharmaceutical company announced positive results from a late-stage study of its CAN-2409 viral immunotherapy for prostate cancer. The dramatic jump in stock price was ...
Targeted Oncology10d
FDA Grants 510(k) Clearance to Ibex Prostate Detect AI for Prostate Cancer
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...